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Over the past decade, great interest has been given to regulatory T (Treg) cells. A vast body of evidence
has shown the existence and highlighted the importance of Treg cells in the active suppression of immune
system responses. This form of immunoregulation is the dominant means utilized by the immune system
to reach a harmony between reciprocal response processes in order to ensure adequate host defense with
minimal host detriment. Therapeutically targeting Treg cells is a direct and powerful means to manip-
ulate the immune system to achieve beneficial effects on various disease pathologies, including allergy,
autoimmunity and cancer, as well as the facilitation of organ transplantation. This powerful target
for immunoregulation is of much concern to practitioners and researchers of complementary and altern-
ative medicine because it allows a great deal of control and certainty in dealing with the prevalence
of debilitating immune system-related disorders for which there has been little remedy outside of
Western Medicine.
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Setting the Stage: Establishing the Pertinence
of Treg Cells to CAM
This review will familiarize complementary and alternative
medicine (CAM) researchers with regulatory T (Treg) cells
and their important role in maintaining homeostasis in immune
system functioning. The goal of this work is 4-fold: (i) to give
an overview of the complex human immune system, (ii) to
assess the methodologies for Treg cell manipulation, (iii) to
present the implications of Treg cell manipulation for thera-
peutic uses, and (iv) to emphasize the relevance Treg cells
have to CAM practitioners and researchers.
A variety of homeopathic remedies have been utilized for
hundreds of years, without any scientific evidence of efficacy,
for the treatment of immune system-related disorders (1).
Modern technologies have afforded researchers the ability to
identify a number of immunomodulatory compounds, isolated
from plants and fungi, and to elucidate their mechanism of
action (2–6). A great deal of these compounds have been
shown to stimulate or suppress the immune system via direct
or indirect Treg cell modulation.
The Brazilian folk medicine, sucupira seed, which has been
used for attenuation of inflammation, has shown clinical and
immunomodulatory effects in collagen II-induced arthritis in
mice. Suppression of B cell and CD4 T cell activation, by
sucupira seed extracts, lends evidence for its usage in chronic
inflammatory diseases (7). Beta-sitosterol (BSS) and sitoster-
olin (beta-sitosterol glucoside, BSSG) are found in leaf
extracts. The combination of the two proves to have profound
anti-inflammatory effects and immunomodulatory actions.
Various natural products, including Ginko and Cat’s Claw,
contain phytosterols; however, it was found that a standardized
mixture, with a ratio of 100 : 1 of sterols to sterolins, is optimal
in restoring appropriate immune system responses (1,8). Sucu-
pira seed extracts and plant sterols and sterolins have been
found to not only alleviate symptoms of inflammation, but
more importantly, repair the underlying immune system
abnormality.
Agaricus blazei Murill, an edible fungus used in traditional
medicine, has stimulating immune system properties.
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mycelia extract induces the expression of interleukin 12
(IL-12), a cytokine involved in the generation of TH1 cells,
and the enhancement of natural killer (NK) cell activity (9).
An alpha-d-glucan polysaccharide from the medicinal plant
Tinospora cordifolia stimulates the TH1 pathway-associated
cytokine profile. Stimulation of T helper cell differentiation
into TH1 cells gives an added boost to cell-mediated immunity
(10). The stimulation of cell-mediated immunity by both of
these natural products may be useful in the successful immune
defense against infection.
The attenuation of inflammation and the enhancement of
cell-mediated immunity presented above are just two of
several potential therapeutic means to treat disease pathol-
ogy using natural products that modulate the immune system
(1,4,11). Myriad compounds from nature have recently been
investigated as to their capabilities for immune stimulation or
suppression, for usage in infection, autoimmunity, allergy
and organ transplant facilitation (6) (Tables 1 and 2).
This review series will commence with an overview of the
development, the actions and the interactions of the constitu-
tive components responsible for the functioning of the human
immune system.
A Multifaceted Cast: The Delicate Structure
and Commanding Functions of Host Defense
The body is protected by a diverse army of cells and molecules
that work in concert to ensure survival through the evolution of
both innate and adaptive immune mechanisms. The ultimate
target that can trigger all immune responses is an antigen,
which is usually a foreign macromolecule. In the presence of
antigens, different cells of the immune system initiate an
elaborate biosignaling pathway which leads to the production
and proliferation of appropriate T cells and the most effica-
cious host defense response (25,26).
Stimulated Mobilization: Initiation and Mediation of
the Immune Response
Initial immune responses to any antigen require that the anti-
gen be recognized by a T lymphocyte (T cell). The surface of
T cells displays T cell receptors (TCRs), which bind to a com-
plex displayed at the surface of an antigen-presenting cell
(APC), which include dendritic cells (DCs) and macrophages.
Two means exist for antigen recognition. For exogenous
antigens, APCs engulf antigen by endocytosis or phagocytosis,
Table 1. Natural products primarily modulating immune system cells
Active ingredient Source Mechanism of action References
Fish oil Fish Regulation of Treg cells (12,13)
Production of IL-10, TNF-a
Suppression of NF-kB activation
Suppression of COX-2, IL-2 and IL-6
Curcumin (diferuloylmethane) Turmeric (Curcuma longa) Activation and regulation of dendrite cells (14,15,16)
Inhibit production of IL-1-b, IL-6 and TNF-a
Inhibition of NF-kB activation
Blocks IL-12 signaling
Expression of DF508 cystic fibrosis
transmembrane conductance regulator
Bromelain Pineapple stems Blocks activation of extracellular
regulatory kinase-2 in T cells
(17,18)
(other hydrolytic enzymes) Inhibition of IL-2, IFN-g and IL-4 expression
Vitamin-C and vitamin-E Citrus fruits Generation of Treg cells (19)
Inhibition of NF-kB activation
Table 2. Natural products modulating cytokine production and activation
Active ingredient Source Mechanism of action References
Resveratrol Skin of red grapes Inhibition of NF-Kb activation (20)
Royal jelly Secretion by worker bees Inhibition of TNF-a and IL-6 production (21)
( )-Epigallocatechin gallate Japanese green tea Inhibition of TNF-a production (22)
Inhibition of DNA damage and lipid peroxidation
Boswellic acid Gum resin of Boswellia serrata tree Downregulation of TNF-a expression (23)
Inhibition of NF-kB signaling
N-acetylcysteine Synthetic Inhibition of NF-kB activation (24)
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within a transmembrane class II histocompatibility molecule,
located on the cell surface. These antigens may be recognized
by CD4
þ T cells. Antigens that are generated within a cell, e.g.
viral proteins, are degraded into fragments and displayed at the
cell surface within a class I histocompatibility molecule. These
may be recognized by cytotoxic CD8
þ T cells, which have the
ability to destroy the infected cell.
Chemokine Attraction: The Beacon for Recruitment
and Organization
Recruitment of appropriate immune system cells to the site of
action is aided by chemokines, which are cytokines that attract
leukocytes. Chemokines bind to chemotactic cytokine recept-
ors (CCRs) on the plasma membrane of leukocytes. Logically,
cell-mediated immune cells and humoral immune cells express
different CCRs. TH1 cells and macrophages express CCR5,
while TH2 cells, eosinophils and basophils express CCR3.
Response Reinforcement: Bolstering and Amplifying
Immune Response through T cell Proliferation
In order for the immune system to mount an adequate defense,
it must produce more T cells, through a process of differenti-
ation and proliferation. Monocytes in peripheral tissues, upon
antigen encounter, secrete monocyte growth factor, which
activates monocytes to develop into macrophages. In turn,
these macrophages, in the presence of bacterial antigens such
as lipopolysaccharides (LPS), trigger the maturation of DCs.
Matured DCs migrate into the lymph nodes to spread the car-
ried antigen, through interactions with lymph node resident
DCs. Increased concentration of bacterial antigen and
cytokines in the lymph nodes, over time, stimulate activated
DCs to interact with naı ¨ve helper T cells (TH0) (27–30).
Depending on various factors related to the immune response
required, the end result of this cascade will be the differenti-
ation of TH0 into TH1, TH2o rT reg cells, followed by clonal
proliferation of that T cell subtype (31).
TH1 cells are responsible for cell-mediated or innate immun-
ity, while TH2 cells are responsible for humoral or adaptive
immunity. Both TH1 and TH2 cells are under the regulatory
influence of Treg cells (Fig. 1).
Cell-Mediated Immunity: The Immutable Guard
TH1 cells are T lymphocytes that belong to the CD4
þ subset.
They participate in cell-mediated immunity which is essential
for controlling intracellular pathogens like viruses and certain
bacteria. Antigen presentation by DCs to the TCR of prema-
ture CD4
þ TH cells coupled with secretion of IL-12, initiates
TH1 cell production. IL-12 stimulates TH1 cells to secrete their
own lymphokines, including tumor-necrosis factor-beta
(TNF-b) and interferon-gamma (IFN-g). These cytokines sti-
mulate macrophages and the recruitment of leukocytes to the
site, resulting in inflammation. TH1 cell action together with
NK cell and macrophage activitymaintain a complex signaling
cascade whose vital goal is the effective destruction of target
cells, especially virally infected or stressed host cells (32–35)
(Fig. 1). In order to reinforce the TH1 immune responses, the
TH2 responses are suppressed in two ways. First, IFN-g and
IL-12,secreted by TH1 cells, inhibit the formation of TH2cells.
Second, IFN-g inhibits class-switching in B cells.
Humoral Immunity: The Plastic Line of Defense
The humoral immune system affords the ability to adequately
protect the host from unanticipated pathogens. This system is
made possible through the generation of a plethora of receptors
which can recognize a wide array of antigens.
TH2 cells are produced in a manner similar to TH1 cells, but
with different paracrine stimulants/cytokines. TH2 cells pro-
vide help for B cells and are essential for antibody-mediated
immunity, which is needed to control extracellular pathogens.
B cells have specialized receptors which bind and engulf sol-
uble antigens through receptor-mediated endocytosis. The
antigen is digested into fragments which are then displayed
at the cellsurface within a class II histocompatibility molecule.
TH2 cells with complementary TCRs bind the B cell and
secrete lymphokines that induce B cell differentiation into a
clone of plasma cells that secrete identical antibodies. These
antibodies recognize and bind to an epitope on an antigen
and trigger a constructive response to the antigen (Fig. 1).
TH2 cells secrete four major lymphokines. Interleukin
4 (IL-4) stimulates class-switching in B cells to promote
synthesis of IgE antibodies and promotes premature TH cells
to enter the TH2 pathway while simultaneously inhibiting the
TH1 differentiation pathway. Interleukin 5 (IL-5) recruits and
activates eosinophils at the site of action. Interleukin 10
(IL-10) inhibits IL-12 production by DCs therefore adding
another inhibitory mechanism to the TH1 differentiation
pathway. Like IL-4, interleukin 13 (IL-13) also promotes the
synthesis of IgE antibodies (36–38).
Reciprocal Inhibition: Rudimentary Mechanisms of
Regulation
A balance between reciprocal responses, TH1 and TH2, is
necessary for the immune system to achieve homeostasis.
Each division, humoral immunity and cell-mediated immun-
ity, has the ability to suppress the other’s functioning, through
inhibitory pathways. Also, there is evidence that each response
is capable of self-inhibition, through negative feedback, when
their respective cytokine production is high. This constitutes a
system of checks-and-balances which ensures that neither type
of immune response is uncontrollable. However, Treg cells
have a much broader and more dominant influence over both
kinds of immune defense.
Regulatory T Cells: Can a Single Cell Type
Actualize Harmony?
Treg cells, secreting IL-10 or TGF-b, are a prevailing
mediator of immunological tolerance and are responsible for
eCAM 2006;3(1) 27the appropriate control, via termination, of both TH1 and TH2
cell-mediated immune responses. They are the essential actor
in the prevention of disease pathology related to the overaction
of either response (39–44).
Treg cells are generated from naı ¨ve T cells after antigenic
stimulation and presentation by DCs. Various data suggests
that Treg cells represent a distinct lineage of T cell develop-
ment (41). Characteristic expression of the inteleukin 2
receptor-alpha (IL-2Ralpha) chain (CD25) and the FOXP3
transcription factor help to differentiate Treg cells as a distinct
subset of CD4
þ T cells (45).
FOXP3 (Forkhead Family Transcription Factor) is essential
to Treg cell lineage commitment, development and function.
In fact, transfer of FOXP3 into naı ¨ve T cells converts them
into Treg cells. The expression of FOXP3 has been found to
correlate with Treg cells ability to suppress immune responses,
indicating a possible function of FOXP3 in the Treg cell-
mediated mechanism for the negative regulation of T cell
activation (42,45–51). These developmental and functional
observations of FOXP3 indicate its importance in Treg cell
function and in regulation of the immune system.
If Treg cells could balance the immune system completely,
there would be no occurrence of immune system-related dis-
orders. The prevalence of immune system-related disorders
indicates that although Treg cells have a great deal of control,
there exist factors responsible for the inappropriate develop-
ment or functioning of immune responses.
Immunological Development: The Hygienic Foundation
of Response Strengthening
According to the hygiene theory, at birth, the human immune
system is immature and favors TH2-like cytokine production.
A wide variety of biological stimuli, ranging from helminth
to viral infections, contracted from siblings or peers, can
induce TH1-like cytokine production and effectively balance
Figure 1. The mediators of immune system responses.
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dren who have little contact with others or live in ‘sterile’
urban environments lack this TH1-like cytokine production
and consequently the TH2-like cytokine response pattern per-
sists unchecked. A bolstering of TH2 cell development during
childhood sacrifices TH1 development and puts individuals at
risk for allergy later in life. The logical progression of this
idea is that once the immune system develops fully, individu-
als will have a far greater capacity for a TH2 reponse to anti-
gen, due to a lack of reciprocal suppression from TH1
cytokine production. This imbalance can result in an increased
risk of asthma and other atopic diseases. Suppressed TH1
development and function may lead to allergic hypersensitiv-
ity, while suppressed TH2 development may result in autoim-
mune disorders. Thus, great interest has been focused on the
biological factors that influence and determine immune system
development and differentiation.
Although this view seems sound, it does not take into
account the observed rise in TH1 cell-mediated autoimmune
diseases in industrialized nations, nor does it address the
inverse relationship between long-term helminth induced
TH2 cytokine response and allergy. Since Treg cells may be
implicated in these discrepancies, researchers now postulate
that Treg cells are the key to substantiate the Hygiene Theory,
which underscores the immense role Treg cells have in proper
immune system functioning (52–59).
Given that immune responses may vary according to the
environment in which individuals have been raised, the
importance of Treg cells in combating this imbalance becomes
apparent. In many cases it seems that Treg cell-mediated
immunomodulation is not strong enough to overcome this
deficiency in development, therefore methodologies to modu-
late Treg activation and functioning may prove fruitful.
The Stage Has Been Set: Treg Cell Essentiality
to the Immune System and CAM
Harmony between the two branches of immunological host
defense is imperative to human health. This review assessed
the intricate tapestry of humoral and cell-mediated immune
functioning, including constituents, interrelationships, feed-
back mechanisms, and reciprocal control. Treg cells have
been shown to maintain a crucial role in keeping the status
quo through suppression of immune functioning. The wealth
of cutting-edge knowledge of Treg cell function in immune
system-related disorders, coupled with substantial evidence
of natural immune system modifiers, makes this cell an excel-
lent target for investigation and application by CAM research-
ers. We now have a solid basis for delving into the specifics
of Treg cell action in the pathology of disease and exploring
the use of Treg cells as a therapeutic target in the treatment
of hypersensitivity, cancer, infection, autoimmunity and
organ transplant facilitation. Already at the molecular level
Ventura (58) has proposed that ‘CAM modalities may deeply
affect both the signaling and transcriptional level of cellular
homeostasis. Such a perception holds promises for a new
era in CAM, prompting reproducible documentation of biolo-
gical responses to CAM-related strategies and compounds.
To this end, functional genomics and proteomics and the
comprehension of the cell signaling networks may substan-
tially contribute to the development of a molecular evidence-
based CAM’.
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